Larimar Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bala Cynwyd, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Larimar Therapeutics, Inc. has filed 693 SEC EDGAR filings since 28 Aug 2006

SEC filing history

Showing 601-625 of 690 matching filings.

Per page
25
Current page
25
8-K File 001-36510

FORM 8-K

Filing date
01 Jul 2015
Reporting date
25 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jun 2015
Reporting date
10 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-204931

FORM S-8

Filing date
12 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jun 2015
Reporting date
01 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 May 2015
Reporting date
15 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 May 2015
Reporting date
15 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36510

FORM 8-K

Filing date
12 May 2015
Reporting date
12 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36510

DEF14A

Filing date
30 Apr 2015
Reporting date
25 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Mar 2015
Reporting date
24 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Mar 2015
Reporting date
24 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Mar 2015
Reporting date
24 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Mar 2015
Reporting date
17 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36510

FORM 8-K

Filing date
19 Mar 2015
Reporting date
19 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Mar 2015
Reporting date
27 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Mar 2015
Reporting date
27 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Mar 2015
Reporting date
27 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Mar 2015
Reporting date
27 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88225

ZAFGEN, INC.

Filing date
13 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88225

SC 13G/A filing

Filing date
13 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88225

ZAFGEN SCHEDULE 13G - 2-12-15

Filing date
12 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88225

SC 13G

Filing date
12 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-201439

424B4

Filing date
23 Jan 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-201439

EFFECT filing

Filing date
22 Jan 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .